Back
Janux Therapeutics Stock Price Chart
Buy
60
JANX
Janux Therapeutics
Last Price:
50.43
Seasonality Move:
-2.97%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JANX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Janux Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.57 | Buy |
| 20-day SMA: | 50.98 | Sell |
| 50-day SMA: | 47.16 | Buy |
| 200-day SMA: | 21.54 | Buy |
| 8-day EMA: | 47.65 | Buy |
| 20-day EMA: | 48.66 | Buy |
| 50-day EMA: | 45.5 | Buy |
| 200-day EMA: | 28.08 | Buy |
Janux Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.54 | Sell |
| Relative Strength Index (14 RSI): | 54.06 | Buy |
| Chaikin Money Flow: | 981360 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.22 - 57.62) | Sell |
| Bollinger Bands (100): | (15.74 - 51.72) | Buy |
Janux Therapeutics Technical Analysis
| May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 16 | 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Janux Therapeutics Stock
Is Janux Therapeutics Stock a Buy?
- Janux Therapeutics share price is 50.41 while JANX 8-day simple moving average is 46.57, which is a Buy signal.
- The stock price of JANX is 50.41 while Janux Therapeutics 20-day SMA is 50.98, which makes it a Sell.
- Janux Therapeutics 50-day simple moving average is 47.16 while JANX share price is 50.41, making it a Buy technically.
- JANX stock price is 50.41 and Janux Therapeutics 200-day simple moving average is 21.54, creating a Buy signal.
JANX Technical Analysis vs Fundamental Analysis
Buy
60
Janux Therapeutics (JANX)
is a Buy
Is Janux Therapeutics a Buy or a Sell?
-
Janux Therapeutics stock is rated a Buy
The current Janux Therapeutics [JANX] share price is $50.41. The Score for JANX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Janux Therapeutics Stock Info
Market Cap:
2.61B
Price in USD:
50.41
Share Volume:
1.13M
Janux Therapeutics 52-Week Range
52-Week High:
65.60
52-Week Low:
5.65
Buy
60
Janux Therapeutics (JANX)
is a Buy
Janux Therapeutics Share Price Forecast
-
What is the Janux Therapeutics stock price today?
The Janux Therapeutics stock price is 50.41 USD today. -
Will JANX stock go up or go down?
Janux Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Janux Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Janux Therapeutics is not overvalued.
Is Janux Therapeutics Stock a Buy?
- Janux Therapeutics share price is 50.41 while JANX 8-day exponential moving average is 47.65, which is a Buy signal.
- The stock price of JANX is 50.41 while Janux Therapeutics 20-day EMA is 48.66, which makes it a Buy.
- Janux Therapeutics 50-day exponential moving average is 45.50 while JANX share price is 50.41, making it a Buy technically.
- JANX stock price is 50.41 and Janux Therapeutics 200-day simple moving average is 28.08, creating a Buy signal.
Fundamental Analysis of Janux Therapeutics
Is Janux Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.05 per share, an increase this year of $0.09 per share, and a decrease next year of $0.57 per share.
Technical Analysis of Janux Therapeutics
Should I short Janux Therapeutics stock?
- JANX Moving Average Covergence Divergence (MACD) indicator is -0.54, suggesting Janux Therapeutics is a Sell
- Janux Therapeutics Relative Strength Index (RSI) is 54.06, which suggest Janux Therapeutics is overbought
- The Bollinger Bands (25) for Janux Therapeutics is (45.22 - 57.62), which suggest Janux Therapeutics is a Buy
- The Bollinger Bands (100) for Janux Therapeutics is (15.74 - 51.72), which suggest Janux Therapeutics is a Buy
* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.